# BRVE (Braveheart Bio, Inc.) - SEC EDGAR Financial Statements

> Braveheart Bio, Inc. reported $514.5M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BRVE
- Markdown: https://convexityos.com/fundamentals/BRVE.md
- SEC CIK: 0002131524
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:27 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002131524&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $121.3M | Total debt: $515K |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.54M | $11.12M | -- | $9.0K | $0 | -- |
| Total Operating Expenses | $30.15M | $15.88M | -- | $59.29M | $381K | -- |
| **Operating Income** | -$30.15M | -$15.88M | -- | -$59.29M | -$381K | -- |
| Interest Income | $3.71M | $889K | -- | $169K | $0 | -- |
| **Net Income** | -$26.50M | -$14.99M | -$14.28M | -$59.12M | -$381K | -$99K |
| Basic EPS | -$0.51 | -$10.99 | -- | -$10.05 | -$0.61 | -- |
| **Diluted EPS** | -$0.51 | -$10.99 | -- | -$10.05 | -$0.61 | -- |
| Basic Shares Outstanding | 52.1M | 1.7M | -- | 5.9M | 637.5K | -- |
| Diluted Shares Outstanding | 52.1M | 1.7M | -- | 5.9M | 637.5K | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Dec 2025 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $121.3M | $122.8M | $89.16M |
| **Cash & Short-Term Investments** | $503.5M | $122.8M | $89.16M |
| **Total Current Assets** | $359.6M | $123.4M | $89.28M |
| Property, Plant & Equipment, Net | $20K | $23K | $0 |
| Other Non-Current Assets | $98K | $70K | $70K |
| **Total Non-Current Assets** | $154.9M | $3.51M | $70K |
| **Total Assets** | $514.5M | $127.0M | $89.35M |
| Accounts Payable | $1.98M | $2.67M | $1.06M |
| Other Current Liabilities | $6.14M | -- | $0 |
| **Total Current Liabilities** | $16.67M | $9.06M | $5.24M |
| Other Non-Current Liabilities | $75K | $86K | $91K |
| **Total Non-Current Liabilities** | $175K | $284K | $91K |
| **Total Liabilities** | $16.85M | $9.34M | $5.33M |
| **Total Debt (incl. Leases)** | $515K | $575K | -- |
| Common Stock | $8.0K | $1.0K | $1.0K |
| Retained Earnings | -$122.4M | -$95.91M | -$66.05M |
| Accumulated Other Comp. Income | -$718K | -- | $0 |
| **Total Stockholders' Equity** | $497.6M | -$95.91M | -$65.87M |
| Total Equity | $497.6M | -$95.91M | -$65.87M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.50M | -$14.99M | -$14.28M | -$59.12M | -$381K | -$99K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 21.57x | 13.63x | -- | -- | -- | -- |
| Quick Ratio | 30.20x | 13.56x | -- | -- | -- | -- |
| Debt to Equity | 0.00x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
